Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 12,601 | 12,418 | 9,597 | 10,424 | 14,351 |
| Operating Income | -12,601 | -12,418 | -9,597 | -10,343 | -14,351 |
| Other Income | 1,033 | 1,065 | 927 | 1,019 | 1,075 |
| Pre-tax Income | -11,568 | -11,353 | -8,670 | -9,324 | -13,276 |
| Net Income Continuous | -11,568 | -11,353 | -8,670 | -9,324 | -13,276 |
| Net Income | $-11,568 | $-11,353 | $-8,670 | $-9,324 | $-13,276 |
| EPS Basic Total Ops | -0.37 | -0.38 | -0.31 | -0.33 | -0.49 |
| EPS Basic Continuous Ops | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 |
| EPS Diluted Total Ops | -0.37 | -0.38 | -0.31 | -0.33 | -0.49 |
| EPS Diluted Continuous Ops | -0.37 | -0.38 | -0.31 | -0.34 | -0.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.38 | -0.31 | -0.33 | -0.49 |
| EBITDA(a) | $-12,399 | $-12,229 | $-9,381 | $-10,225 | $-14,151 |